Loading company…
Perfuse Therapeutics develops therapies to improve retinal blood flow and treat eye diseases.
Perfuse Therapeutics develops therapies intended to improve retinal blood flow in conditions such as glaucoma and diabetic retinopathy. Founded by Sevgi Gurkan and based in San Francisco, the company raised USD 9.00 mn in Series A funding in July 2020 from Catalio Capital Management, Hatteras Venture Partners, Lilly Asia Ventures, and OrbiMed Advisors.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in